It has been put forward that FOXM1 is a major factor of adverse prognosis in 18,000 cancer cases across 39 human malignancies, confirming the important role of FOXM1 in cancer (Gentles et al., 2015; Gartel, 2017). The gene discussed is FOXM1; the disease is cancer.